Page 2 - 2 Dg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lee Pharma informed they would file application for getting approval from drug regulator.(FILE) New Delhi: Hyderabad-based Lee Pharma has entered into an agreement with the Indian Institute of Chemical Technology (IICT), a constituent laboratory of CSIR, to manufacture and commercialise 2-Deoxy-D-Glucose (2-DG) used to treat Covid patients, a statement said on Wednesday. An integrated pharmaceutical company, Lee Pharma entered into the non-exclusive licensing agreement for the synthesis of 2-DG, recently developed by DRDO and Dr Reddy's Laboratories. The drug has received approval for use in...

Guidelines for Using Anti-COVID Drug 2-DG are Out Now by Saisruthi Sankaranarayanan on  June 3, 2021 at 7:07 PM "Directions for use of 2-DG in COVID-19 patients as per DCGI approval" This "Made-in-India" drug 2-Deoxy-D-Glucose was developed by DRDO. Previously, the first batch of this drug was released on 17 May by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan. Key takeaways from the guidelines ‘2-DG must be prescribed to patients who developed moderate to severe forms of SARS-CoV-2 infections and caution must be exercised while using it on people w...

2-DG is safe and effective, but not meant for people with underlying health problems, says DRDO in its directions for use of this anti-COVID-19 drug.

COVID-19 drug 2-DG not for everyone, DRDO issues directions for usage COVID-19 drug 2-DG not for everyone, DRDO issues directions for usage The drug could be a game-changer in the battle against the pandemic as it helps in faster recovery of hospitalised patients. Share Updated: Jun 1, 2021, 11:48 PM IST The Defence Research and Development Organisation (DRDO) on Tuesday issued directions on the usage of the new COVID-19 drug 2-DG. The DRDO said that patients with uncontrolled diabetes, severe cardiac problem, acute respiratory distress syndrome (ARDS), severe hepatic and renal impairment sho...

Dr Reddy's Labarotaries has announced the price of 2-DG drug for Covid-19 patients at Rs 990 per sachet, developed by DRDO in collaboration with Dr Reddys. Government hospitals, central and state governments would be provided with the medicine at a discounted price, said an official. This drug is available in powder form and can be consumed orally by dissolving it in water.